Safety and Efficacy of Intracranial Thrombus Aspiration Catheter in the Treatment of Acute Large-vessel Occlusive Stroke

NCT05101668 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 26

Last updated 2023-04-27

No results posted yet for this study

Summary

A prospective, multicenter, single-arm objective performance criteria trial to investigate the safety and efficacy of SINOMED ADPAT for Recanalization Therapy in acute large-vessel occlusive stroke.

Conditions

  • Aspiration
  • Acute Ischemic Stroke
  • Large-vessel Occlusion

Interventions

DEVICE

Intracranial Thrombosis Aspiration Catheter

Direct Aspiration

Sponsors & Collaborators

  • Sinomed Neurovita Technology Inc.

    lead INDUSTRY

Principal Investigators

  • Qingwu Yang, M.D/Ph.D · The Second Affiliated Hospital of Army Medical University

  • Yimin Liu, M.D/Ph.D · Wuhan University

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-10-08
Primary Completion
2022-07-18
Completion
2022-08-17

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05101668 on ClinicalTrials.gov